Anthropic holds pre-IPO meeting as revenue growth draws scrutiny

By Splitfeed EditorialLast updated Oct 15, 2026, 20:20 UTC

On October 15, 2026, Anthropic held a pre-IPO investor meeting in which the company disclosed surging revenue figures and presented its AI capabilities, with particular emphasis on so-called "thinking" features. The meeting also touched on existential risk, with Anthropic representatives apparently dismissing concerns about human extinction scenarios. The company is reported to be targeting a $2 trillion valuation for its upcoming public offering, a figure that has drawn immediate scrutiny given the revenue numbers disclosed.

The tension at the center of this story is between the scale of the valuation sought and the pace of commercial growth supporting it. A $2 trillion target would place Anthropic among the most valuable companies ever to go public, and analysts and observers appear divided on whether the revenue trajectory justifies that ambition. A separate strand of the story complicates the picture further: reports suggest that Anthropic's active enforcement against AI copycat products, while defensible as a brand and quality-control measure, may be constraining the very revenue growth the IPO depends on. That trade-off between protecting the product ecosystem and maximizing commercial reach is a genuine strategic tension, not simply a matter of spin.

Because no specific reactions from the Pro-AI, Anti-AI, or Middle Ground camps have been published yet, only general expectations can be offered. Pro-AI voices would typically emphasize the revenue surge as validation of Anthropic's model and point to the IPO as a sign of mainstream confidence in frontier AI development. The Anti-AI camp, by contrast, would be expected to treat the revenue shortfall critique as evidence that the commercial case for large language model companies is overstated, and the "AI doomers" framing in headlines like the Business Insider piece suggests some critics are already leaning into that narrative, characterizing the figures as insufficient for the valuation sought. Middle-ground observers would likely focus on the structural question, whether any AI company can sustain the growth rates needed to justify valuations in the trillions, without taking a firm position on whether AI development itself is beneficial or harmful.

The argument will sharpen considerably once Anthropic files formal IPO documentation, which would include audited revenue figures, growth rates, and risk disclosures that are currently unavailable to the public. The pricing roadshow and any subsequent S-1 or equivalent filing would give analysts the hard numbers needed to evaluate whether the $2 trillion target is grounded in defensible projections or front-running enthusiasm.